• News
  • BioTech

Ebola drug provided for infected Americans by SD's Mapp Biopharma

Aug. 5 (Bloomberg) -- A tiny San Diego-based company provided an experimental Ebola treatment for two Americans infected with the deadly virus in Liberia. The biotechnology drug, produced with tobacco plants, appears to be working.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!